NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000180

Registered date:12/09/2005

A pilot phaseII study of 3 dimensional stereotactic radiotherapy (3D-SRT) followed by maintenance therapy with oral UFT for stage IB non - small cell lung cancer

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiednon - small cell lung cancer, stageIB.
Date of first enrollment2004/12/01
Target sample size30
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Oral UFT 250mg/m2 therapy for two years from the 57th day after 3 dimensional stereotactic radiotherapy (3D-SRT) which consists of consecutive 4 days of 12 Gray irradiation per fraction per day (total 48Gy)

Outcome(s)

Primary Outcome3-year survival
Secondary OutcomeProgression free survival, median survival time, local progression free survival time, local progression free survival at 3 years, pattern of progression or recurrence, adverse events, 5-year survival rate, local progression free survival at 5 years

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum85years-old
GenderMale and Female
Include criteria
Exclude criteria1)Apparent interstitial pneumonitis or fibrosis on chest X ray 2)Irradiation field larger than half of a ipsilateral lung 3)Double cancer within 5 years except for carcinoma in situ, intramucosal tumor, and basal cell carcinoma of the skin 4)History of previous chemotherapy 5)Pregnant woman, lactating woman, woman who has a possibility of pregnancy 6)Uncontrolled angina pectoris, myocardial infarction and congestive heart failure within three months 7)Uncontrolled diabetes mellitus 8)Active infectious disease 9)Fever more than 38 degrees Celsius 10)Steroid administration 11)Other complication unsuitable for the study

Related Information

Contact

public contact
Name Reiko Naya
Address 2-2 Minatomajima-Minamimachi Chuo-ku Kobe 650-0047, Japan Japan
Telephone 078-304-5200
E-mail naya@kcgh.gr.jp
Affiliation Institute of Biomedical Research and Innovation Department of Translational Research Division of Integrated Oncology
scientific contact
Name Nobuyuki Katakami
Address 2-2 Minatomajima-Minamimachi Chuo-ku Kobe 650-0047, Japan Japan
Telephone 078-304-5200
E-mail
Affiliation Institute of Biomedical Research and Innovation Department of Translational Research Division of Integrated Oncology